Fund Name | Location |
3L Capital | California, Los Angeles, United States |
Axia8 Ventures | China, Shanghai, Shanghai |
Beijing Dabeinong Technology Group | Beijing, China, Haidian |
Delta Link Capital | Beijing, Beijing, China |
Denny Hill Capital | Seattle, United States, Washington |
Duke Management Company | Durham, North Carolina, United States |
EPIQ Capital Group | California, San Francisco, United States |
Fuzhou Zhengtong Touzi Youxian Gongsi | China, Foochow, Fujian |
Grupo Sanborns | Distrito Federal, Mexico, Mexico City |
Juneau Capital | Israel, Tel Aviv, Tel Aviv District |
Michaelson Capital Partners | New York, New York, United States |
Money Partners Group | Japan, Tokyo |
Rimon Funds | Herzliya, Israel, Tel Aviv |
Sercel | Carquefou, France, Pays de la Loire |
Shenzhen Gemboom Investment Management | China, Guangdong, Shenzhen |
Urban Capital Network | Houston, Texas, United States |
Virgo Capital | Austin, Texas, United States |
Weierde Intelligent Equipment | China, Guangdong, Shenzhen |
Xinjiang Zhongyi Wenhua | Changji, China, Xinjiang |
Zhongfu Investment Group | Beijing, Beijing, China |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Orbiepharm | $4M | 20 Jun 2016 | Haidian District, Beijing, China | ||
Rainbow | $10M | 06 Apr 2016 | Jingan, Shanghai, China | ||
$463K | 28 Apr 2013 | China, Wuwei, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Orbiepharm | $4M | 20 Jun 2016 | Haidian District, Beijing, China | ||
Rainbow | $10M | 06 Apr 2016 | Jingan, Shanghai, China | ||
$463K | 28 Apr 2013 | China, Wuwei, China |